Beijing Tiantan Biological Products (SHSE:600161) Interest Expense : ¥1 Mil (TTM As of Mar. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Beijing Tiantan Biological Products Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Beijing Tiantan Biological Products's interest expense for the three months ended in Mar. 2024 was ¥ -1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Beijing Tiantan Biological Products's Operating Income for the three months ended in Mar. 2024 was ¥ 492 Mil. Beijing Tiantan Biological Products's Interest Expense for the three months ended in Mar. 2024 was ¥ -1 Mil. Beijing Tiantan Biological Products's Interest Coverage for the quarter that ended in Mar. 2024 was 410.48. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Beijing Tiantan Biological Products Interest Expense Historical Data

The historical data trend for Beijing Tiantan Biological Products's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tiantan Biological Products Interest Expense Chart

Beijing Tiantan Biological Products Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.90

-2.98

-3.09

-2.41

-3.66

Beijing Tiantan Biological Products Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-5.59	2.93	-1.39	0.39	-1.20

Beijing Tiantan Biological Products Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1 Mil.

Beijing Tiantan Biological Products (SHSE:600161) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Beijing Tiantan Biological Products's Interest Expense for the three months ended in Mar. 2024 was ¥-1 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥492 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥28 Mil.

Beijing Tiantan Biological Products's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	491.751	/	-1.198
	=	410.48

The higher the ratio, the stronger the company's financial strength is.

Beijing Tiantan Biological Products (SHSE:600161) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

No. 4 Sanjianfang South Li, Zhongdan Center, Beijing, CHN, 100024

Website

http://www.tiantanbio.com

Beijing Tiantan Biological Products Corp Ltd is a China-based company engaged in the research and development, manufacturing, sales and consulting services for blood products. The company's blood products include Shanghai Blood Human Albumin, Shanghai blood system intravenous injection of human immunoglobulin, Guizhou blood human albumin, Rongsheng human albumin, Guizhou blood system static injection immunoglobulin, Rongsheng tetanus human immunoglobulin and others.

Executives

Wang Jian Ming	Supervisors
Liu Ya Na	Directors, senior managers
Fu Dao Xing	Directors, senior managers
He Yan Lin	Directors, senior managers
Hu Li Gang	Director
Ci Xiang	senior management
Yang Hui Chuan	Director
Zhang Yi	senior management
Wu Zhen Shan	senior management

Beijing Tiantan Biological Products (SHSE:600161) Headlines

No Headlines